This provider's $3.8M in total Medicare payments ranks in the 96th percentile of Hematology-Oncology providers nationally.
Medicare payments to this provider grew 140% from 2014 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 204% in 2015
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $381.32 | $221.47 | 1.72x | $159.85 | $107.1K | 692 | 368 |
| 2015 | $352.67 | $159.29 | 2.21x | $193.38 | $325.1K | 2.6K | 810 |
| 2016 | $279.28 | $128.78 | 2.17x | $150.50 | $376.0K | 3.0K | 1.2K |
| 2017 | $494.87 | $128.92 | 3.84x | $365.95 | $458.0K | 4.1K | 1.6K |
| 2018 | $855.99 | $217.36 | 3.94x | $638.63 | $733.6K | 6.5K | 2.5K |
| 2019 | $719.76 | $149.03 | 4.83x | $570.73 | $296.9K | 4.4K | 1.5K |
| 2020 | $641.84 | $122.29 | 5.25x | $519.55 | $525.5K | 5.7K | 1.6K |
| 2021 | $594.06 | $97.92 | 6.07x | $496.14 | $422.9K | 5.7K | 1.8K |
| 2022 | $317.25 | $54.67 | 5.80x | $262.58 | $320.5K | 5.5K | 2.1K |
| 2023 | $303.48 | $48.45 | 6.26x | $255.03 | $257.1K | 4.8K | 1.9K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| J2505 | Injection, pegfilgrastim, 6 mg | 466 | $1.4M | $3.1K | 3.48x |
| 96413 | Infusion of chemotherapy into a vein up to 1 hour | 4.3K | $487.6K | $114.42 | 5.76x |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | 5.8K | $349.5K | $60.76 | 2.45x |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | 2.4K | $211.2K | $89.37 | 2.50x |
| J1454 | Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 491 | $210.5K | $428.75 | 3.38x |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | 730 | $90.7K | $124.26 | 2.47x |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | 835 | $70.8K | $84.85 | 2.78x |
| G0498 | Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 504 | $70.1K | $139.02 | 7.09x |
| 96401 | Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle | 1.0K | $63.9K | $62.61 | 3.32x |
| 96417 | Infusion of different chemotherapy drug or substance into a vein up to 1 hour | 1.2K | $63.4K | $55.00 | 5.74x |
| J9999 | Not otherwise classified, antineoplastic drugs | 15 | $62.8K | $4.2K | 3.09x |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 400 | $62.6K | $156.41 | 21.17x |
| J3490 | Unclassified drugs | 82 | $60.8K | $741.86 | 3.00x |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | 364 | $58.8K | $161.46 | 2.69x |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | 319 | $50.5K | $158.36 | 2.63x |
| 96375 | Injection of different drug or substance into a vein for therapy, diagnosis, or prevention | 2.8K | $40.8K | $14.69 | 7.09x |
| 96367 | Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour | 1.5K | $37.8K | $25.25 | 5.60x |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | 650 | $36.3K | $55.83 | 5.25x |
| J9310 | Injection, rituximab, 100 mg | 41 | $28.9K | $705.01 | 3.10x |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | 476 | $27.9K | $58.66 | 2.80x |
This provider submits charges 4.19 times higher than what Medicare actually pays.
A markup ratio of 4.19x means for every $100 Medicare pays, this provider initially charges $419. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Hematology-Oncology providers in DE for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Jamal Misleh, MD | Newark, DE | $36.6M | ⚠️ Flagged |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data